Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is 24.14.
Forward PE Ratio (24.14) = Close Price ($203.74) / Consensus Forward EPS ($8.50)
FORWARD PE RATIO
24.14
SECTOR MEDIAN · HEALTHCARE
19.84
median of 78 covered companies
CURRENT VS SECTOR MEDIAN
+21.70%
vs the sector median at left
Danaher Corporation
Market Cap
$143.23B
Forward PE Ratio
24.14
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Danaher Corporation (DHR) | $143.23B | 24.14 |
| Vertex Pharmaceuticals Incorporated (VRTX)vs › | $132.36B | 28.21 |
| Bristol-Myers Squibb Company (BMY)vs › | $131.94B | 9.34 |
| Pfizer Inc. (PFE)vs › | $158.42B | 9.34 |
| Intuitive Surgical, Inc. (ISRG)vs › | $124.38B | 32.42 |
| CVS Health Corp. (CVS)vs › | $120.58B | 12.01 |
| Medtronic plc (MDT)vs › | $118.72B | 16.74 |
| Gilead Sciences, Inc. (GILD)vs › | $180.65B | N/A |
| Stryker Corporation (SYK)vs › | $104.79B | 18.41 |
| McKesson Corporation (MCK)vs › | $104.65B | 22.79 |
Trailing P/E
36.5
reported TTM EPS
Forward P/E
24.1
consensus next-FY EPS
The gap between the two multiples is the consensus growth expectation: analysts' forward EPS of $8.50 implies +51.0% EPS growth vs the reported trailing $5.63.
At today's $203.74 close, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $8.50 | $8.44 – $8.52 | 15 | 24.0x |
| 2027-12-31 | $9.29 | $9.16 – $9.39 | 15 | 21.9x |
| 2028-12-31 | $10.20 | $9.09 – $10.71 | 7 | 20.0x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
